Frontier Inflammasome Therapeutics: Capitalizing on Inflammasome Structure to Function for Drugs Beyond NLRP3
Time: 11:00 am
day: day 1 pre lunch track 1
Details:
- Considerations of inflammasome assembly, regulation, and signalling to identify therapeutic targets
- Assessing the opportunity mechanistically to develop new drug candidates beyond NLRP3 inhibitors
